Monoclonal Antibodies for Infectious Diseases Market Estimations (2025 - 2035)
The monoclonal antibodies for infectious diseases market covers monoclonal antibodies used to prevent or treat infectious diseases, including RSV antibodies for infants, COVID-19 pre-exposure antibodies, HIV antibodies, rabies antibodies and biodefence antibodies for anthrax and Ebola, for prophylaxis and treatment, supplied to hospitals, clinics and pediatric offices and government stockpiles.
📄Report ID:2511
|
📊Format: Databook
|
📅Published: 18 November 2026
|
⚡Delivery: Immediate